Nigeria becomes first country to roll out new meningitis vaccine

Nigeria becomes first country to roll out new meningitis vaccine

Daily Current Affairs / Nigeria becomes first country to roll out new meningitis vaccine

Change Language English Hindi

Category : Science and Tech Published on: April 18 2024

Share on facebook

Nigeria has become the first country to administer the Men5CV/MenFive conjugate vaccine, recommended by the WHO, providing protection against five strains of meningococcal bacteria.
The MenFive vaccine targets Neisseria meningitidis groups A, C, Y, W, and X, offering protection for individuals aged 9 months to 85 years, particularly crucial in regions like Nigeria where multiple serogroups are prevalent.
Developed through a 13-year partnership between PATH and the Serum Institute of India, with funding from the UK government's Foreign, Commonwealth and Development Office and support from the Gavi Vaccine Alliance, this vaccine aims to curb meningitis cases in Africa, where Nigeria is among the 26 high-incidence countries.

Recent Post's

New Zealand introduces Parent Boost Visa with a 10-year stay provision for immigrants’ parents.
Read More....
Indian forces conduct high-risk operation to rescue fire-hit Singaporean vessel near Kochi.
Read More....
India launches green skills-based EV training program in partnership with Shell.
Read More....
Sun Pharma appoints Kirti Ganorkar as new Managing Director from September 1, 2025.
Read More....
SBI General Insurance names Mohd. Arif Khan as Deputy CEO to boost leadership strength.
Read More....
Ganesh Baliga appointed as MD and Head of Citi India Solutions to expand tech base.
Read More....
HBL Engineering secures ₹133 crore contract for Kavach railway safety system.
Read More....
Samay Project Services IPO worth ₹14.69 crore opens for public subscription.
Read More....
Amazon signs 17-year nuclear energy deal with Talen for powering AWS data centers.
Read More....
Iran halts partial gas output at South Pars after Israeli airstrike triggers fire.
Read More....